US Stock MarketDetailed Quotes

Denali Therapeutics (DNLI)

Watchlist

19.800
+0.340+1.75%

Close May 13 16:00 ET

3.14BMarket Cap-6.88P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics (DNLI) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.20%-131.2M

-18.67%-412.6M

-17.71%-98.54M

-81.43%-107.3M

17.45%-75.3M

-15.71%-131.47M

2.88%-347.69M

15.15%-83.72M

32.31%-59.14M

19.39%-91.22M

Net income from continuing operations

3.40%-128.45M

-21.23%-512.54M

-12.02%-128.55M

-18.39%-126.9M

-25.34%-124.12M

-30.62%-132.97M

-191.12%-422.77M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

Operating gains losses

----

---14.54M

--0

Depreciation and amortization

17.09%3.76M

64.72%14.81M

44.41%3.78M

70.21%3.86M

103.71%3.96M

48.57%3.21M

-46.24%8.99M

20.30%2.62M

2.35%2.27M

-15.01%1.94M

Other non cash items

18.97%-850K

-8.03%-4.4M

-4.48%-1.1M

-9.06%-1.14M

-9.13%-1.11M

-9.61%-1.05M

-9.60%-4.07M

-9.84%-1.05M

-9.61%-1.05M

-9.81%-1.02M

Change In working capital

-25.36%-27.5M

-99.12%149K

-52.48%5.02M

-120.50%-6.22M

385.41%23.29M

-38.73%-21.93M

105.84%16.94M

80.46%10.56M

788.70%30.35M

97.39%-8.16M

-Change in prepaid assets

91.99%-2.29M

78.23%-540K

1,104.83%1.75M

-92.30%1.36M

1,689.62%24.96M

-52.44%-28.61M

39.42%-2.48M

102.42%145K

20,257.47%17.71M

-143.47%-1.57M

-Change in payables and accrued expense

-50.26%-18.52M

-250.59%-7.06M

698.91%9.32M

-110.78%-2.18M

88.96%-1.87M

-516.95%-12.33M

-7.76%4.69M

-112.72%-1.56M

726.60%20.21M

38.29%-16.93M

-Change in other current assets

25.77%-700K

28.03%772K

-129.93%-533K

-45.76%-1.72M

--3.97M

---943K

--603K

--1.78M

---1.18M

--0

-Change in other current liabilities

----

--0

----

--0

----

-Change in other working capital

-130.01%-5.99M

-50.65%6.97M

-154.17%-5.52M

42.35%-3.69M

---3.77M

--19.94M

104.86%14.13M

--10.19M

-404.42%-6.4M

----

Cash from discontinued investing activities

Operating cash flow

0.20%-131.2M

-18.67%-412.6M

-17.71%-98.54M

-81.43%-107.3M

17.45%-75.3M

-15.71%-131.47M

2.88%-347.69M

15.15%-83.72M

32.31%-59.14M

19.39%-91.22M

Investing cash flow

Cash flow from continuing investing activities

403.84%94.46M

387.62%255.28M

-87.94%20.77M

-38.25%57.83M

60.23%157.94M

104.14%18.75M

-135.60%-88.76M

135.75%172.21M

-7.19%93.66M

-41.35%98.57M

Net PPE purchase and sale

51.44%-2.47M

40.28%-9.5M

70.07%-1.52M

135.48%1.38M

10.61%-4.28M

-136.19%-5.08M

-22.98%-15.91M

-127.83%-5.09M

-87.81%-3.88M

18.19%-4.79M

Net investment purchase and sale

306.81%96.93M

463.49%264.78M

-87.43%22.29M

-42.12%56.45M

56.95%162.21M

105.28%23.83M

-127.78%-72.84M

135.51%177.3M

-5.28%97.54M

-40.57%103.36M

Cash from discontinued investing activities

Investing cash flow

403.84%94.46M

387.62%255.28M

-87.94%20.77M

-38.25%57.83M

60.23%157.94M

104.14%18.75M

-135.60%-88.76M

135.75%172.21M

-7.19%93.66M

-41.35%98.57M

Financing cash flow

Cash flow from continuing financing activities

5,922.54%219.04M

-60.93%189.22M

4,709.72%192.13M

95.81%-778K

-75.98%1.62M

-100.75%-3.76M

2,617.76%484.3M

-188.59%-4.17M

-844.74%-18.56M

-25.09%6.76M

Net issuance payments of debt

99.61%-17K

74.74%-8.17M

99.81%-16K

94.33%-1.36M

---2.43M

---4.36M

---32.34M

---8.32M

---24.02M

--0

Net common stock issuance

----

-62.09%189.25M

--189.25M

--0

--499.25M

--0

Proceeds from stock option exercised by employees

3,103.53%19.06M

-51.35%8.46M

-22.41%3.22M

-89.31%583K

-39.95%4.06M

-41.78%595K

-2.42%17.39M

-11.69%4.16M

118.94%5.46M

-25.09%6.76M

Net other financing activities

--200M

---324K

----

Cash from discontinued financing activities

Financing cash flow

5,922.54%219.04M

-60.93%189.22M

4,709.72%192.13M

95.81%-778K

-75.98%1.62M

-100.75%-3.76M

2,617.76%484.3M

-188.59%-4.17M

-844.74%-18.56M

-25.09%6.76M

Net cash flow

Beginning cash position

18.07%208.43M

37.19%176.54M

2.01%94.07M

89.25%144.31M

-3.37%60.05M

37.19%176.54M

-41.39%128.68M

-38.36%92.21M

-42.90%76.25M

-10.75%62.15M

Current changes in cash

256.50%182.3M

-33.35%31.9M

35.62%114.36M

-414.87%-50.24M

497.38%84.26M

-75.08%-116.48M

152.67%47.85M

503.37%84.32M

-0.51%15.96M

-77.93%14.11M

End cash Position

550.65%390.73M

18.07%208.43M

2.01%94.07M

89.25%144.31M

-3.37%60.05M

37.19%176.54M

-38.36%92.21M

-42.90%76.25M

Free cash flow

2.11%-133.67M

-16.09%-422.1M

-12.67%-100.06M

-68.06%-105.92M

17.11%-79.58M

-17.95%-136.55M

1.97%-363.61M

11.98%-88.81M

29.53%-63.02M

19.34%-96.01M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.20%-131.2M	-18.67%-412.6M	-17.71%-98.54M	-81.43%-107.3M	17.45%-75.3M	-15.71%-131.47M	2.88%-347.69M	15.15%-83.72M	32.31%-59.14M	19.39%-91.22M
Net income from continuing operations	3.40%-128.45M	-21.23%-512.54M	-12.02%-128.55M	-18.39%-126.9M	-25.34%-124.12M	-30.62%-132.97M	-191.12%-422.77M	3.95%-114.75M	-7.89%-107.19M	-154.00%-99.03M
Operating gains losses	----	----	----	----	----	----	---14.54M	--0	--0	--0
Depreciation and amortization	17.09%3.76M	64.72%14.81M	44.41%3.78M	70.21%3.86M	103.71%3.96M	48.57%3.21M	-46.24%8.99M	20.30%2.62M	2.35%2.27M	-15.01%1.94M
Other non cash items	18.97%-850K	-8.03%-4.4M	-4.48%-1.1M	-9.06%-1.14M	-9.13%-1.11M	-9.61%-1.05M	-9.60%-4.07M	-9.84%-1.05M	-9.61%-1.05M	-9.81%-1.02M
Change In working capital	-25.36%-27.5M	-99.12%149K	-52.48%5.02M	-120.50%-6.22M	385.41%23.29M	-38.73%-21.93M	105.84%16.94M	80.46%10.56M	788.70%30.35M	97.39%-8.16M
-Change in prepaid assets	91.99%-2.29M	78.23%-540K	1,104.83%1.75M	-92.30%1.36M	1,689.62%24.96M	-52.44%-28.61M	39.42%-2.48M	102.42%145K	20,257.47%17.71M	-143.47%-1.57M
-Change in payables and accrued expense	-50.26%-18.52M	-250.59%-7.06M	698.91%9.32M	-110.78%-2.18M	88.96%-1.87M	-516.95%-12.33M	-7.76%4.69M	-112.72%-1.56M	726.60%20.21M	38.29%-16.93M
-Change in other current assets	25.77%-700K	28.03%772K	-129.93%-533K	-45.76%-1.72M	--3.97M	---943K	--603K	--1.78M	---1.18M	--0
-Change in other current liabilities	----	--0	----	----	----	----	--0	----	----	----
-Change in other working capital	-130.01%-5.99M	-50.65%6.97M	-154.17%-5.52M	42.35%-3.69M	---3.77M	--19.94M	104.86%14.13M	--10.19M	-404.42%-6.4M	----
Cash from discontinued investing activities
Operating cash flow	0.20%-131.2M	-18.67%-412.6M	-17.71%-98.54M	-81.43%-107.3M	17.45%-75.3M	-15.71%-131.47M	2.88%-347.69M	15.15%-83.72M	32.31%-59.14M	19.39%-91.22M
Investing cash flow
Cash flow from continuing investing activities	403.84%94.46M	387.62%255.28M	-87.94%20.77M	-38.25%57.83M	60.23%157.94M	104.14%18.75M	-135.60%-88.76M	135.75%172.21M	-7.19%93.66M	-41.35%98.57M
Net PPE purchase and sale	51.44%-2.47M	40.28%-9.5M	70.07%-1.52M	135.48%1.38M	10.61%-4.28M	-136.19%-5.08M	-22.98%-15.91M	-127.83%-5.09M	-87.81%-3.88M	18.19%-4.79M
Net investment purchase and sale	306.81%96.93M	463.49%264.78M	-87.43%22.29M	-42.12%56.45M	56.95%162.21M	105.28%23.83M	-127.78%-72.84M	135.51%177.3M	-5.28%97.54M	-40.57%103.36M
Cash from discontinued investing activities
Investing cash flow	403.84%94.46M	387.62%255.28M	-87.94%20.77M	-38.25%57.83M	60.23%157.94M	104.14%18.75M	-135.60%-88.76M	135.75%172.21M	-7.19%93.66M	-41.35%98.57M
Financing cash flow
Cash flow from continuing financing activities	5,922.54%219.04M	-60.93%189.22M	4,709.72%192.13M	95.81%-778K	-75.98%1.62M	-100.75%-3.76M	2,617.76%484.3M	-188.59%-4.17M	-844.74%-18.56M	-25.09%6.76M
Net issuance payments of debt	99.61%-17K	74.74%-8.17M	99.81%-16K	94.33%-1.36M	---2.43M	---4.36M	---32.34M	---8.32M	---24.02M	--0
Net common stock issuance	----	-62.09%189.25M	--189.25M	--0	--0	--0	--499.25M	--0	--0	--0
Proceeds from stock option exercised by employees	3,103.53%19.06M	-51.35%8.46M	-22.41%3.22M	-89.31%583K	-39.95%4.06M	-41.78%595K	-2.42%17.39M	-11.69%4.16M	118.94%5.46M	-25.09%6.76M
Net other financing activities	--200M	---324K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	5,922.54%219.04M	-60.93%189.22M	4,709.72%192.13M	95.81%-778K	-75.98%1.62M	-100.75%-3.76M	2,617.76%484.3M	-188.59%-4.17M	-844.74%-18.56M	-25.09%6.76M
Net cash flow
Beginning cash position	18.07%208.43M	37.19%176.54M	2.01%94.07M	89.25%144.31M	-3.37%60.05M	37.19%176.54M	-41.39%128.68M	-38.36%92.21M	-42.90%76.25M	-10.75%62.15M
Current changes in cash	256.50%182.3M	-33.35%31.9M	35.62%114.36M	-414.87%-50.24M	497.38%84.26M	-75.08%-116.48M	152.67%47.85M	503.37%84.32M	-0.51%15.96M	-77.93%14.11M
End cash Position	550.65%390.73M	18.07%208.43M	18.07%208.43M	2.01%94.07M	89.25%144.31M	-3.37%60.05M	37.19%176.54M	37.19%176.54M	-38.36%92.21M	-42.90%76.25M
Free cash flow	2.11%-133.67M	-16.09%-422.1M	-12.67%-100.06M	-68.06%-105.92M	17.11%-79.58M	-17.95%-136.55M	1.97%-363.61M	11.98%-88.81M	29.53%-63.02M	19.34%-96.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm